Pharming Group reports financial results for the first half of 2021
Recovery continued into Q2 2021 as patient enrollment and product demand increases
Pharming Group presents its preliminary (unaudited) financial report for the first six months of 2021 ended June 30, 2021.
The company held an analyst call at 13:00CET, to rewatch the analyst call please go to: https://webcast.openbriefing.com/pharming-aug21/
Slides for the call are available below.
We are confident this positive trend will continue for the remainder of the year and, supported by our strong cash position, will enable us to continue our planned investment in R&D and the ongoing preparations for the launch of leniolisib- Sijmen de Vries - CEO